tradingkey.logo
tradingkey.logo
Search

Check Cap Ltd

CHEK
Add to Watchlist
1.610USD
0.0000.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
8.00MMarket Cap
LossP/E TTM

More Details of Check Cap Ltd Company

Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.

Check Cap Ltd Info

Ticker SymbolCHEK
Company nameCheck Cap Ltd
IPO dateFeb 19, 2015
CEOOvadia (Alex)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endFeb 19
Address29 Abba Hushi Ave.
City
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code3009000
Phone97248303401
Websitehttps://check-cap.com/
Ticker SymbolCHEK
IPO dateFeb 19, 2015
CEOOvadia (Alex)

Company Executives of Check Cap Ltd

Name
Name/Position
Position
Shareholding
Change
Mr. Boaz Shpigelman
Mr. Boaz Shpigelman
Vice President - Research and Development
Vice President - Research and Development
--
--
Ms. Clara Ezed
Ms. Clara Ezed
Independent Director
Independent Director
--
--
Mr. Joshua (Shuki) Belkar
Mr. Joshua (Shuki) Belkar
Vice President - Operations
Vice President - Operations
--
--
Mr. Israel Hershko
Mr. Israel Hershko
Vice President - Quality Assurance and Regulatory Affairs
Vice President - Quality Assurance and Regulatory Affairs
--
--
Ms. Irina Koffler
Ms. Irina Koffler
Investor Relations
Investor Relations
--
--
Dr. Hanit Brenner-lavie
Dr. Hanit Brenner-lavie
Vice President - Clinical Affairs
Vice President - Clinical Affairs
--
--
Mr. Dan Hilerowitz
Mr. Dan Hilerowitz
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Yoav Kimchy, Ph.D.
Dr. Yoav Kimchy, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Alex Ovadia
Mr. Alex Ovadia
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Steven J. Hanley
Mr. Steven J. Hanley
Chairman of the Board
Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Boaz Shpigelman
Mr. Boaz Shpigelman
Vice President - Research and Development
Vice President - Research and Development
--
--
Ms. Clara Ezed
Ms. Clara Ezed
Independent Director
Independent Director
--
--
Mr. Joshua (Shuki) Belkar
Mr. Joshua (Shuki) Belkar
Vice President - Operations
Vice President - Operations
--
--
Mr. Israel Hershko
Mr. Israel Hershko
Vice President - Quality Assurance and Regulatory Affairs
Vice President - Quality Assurance and Regulatory Affairs
--
--
Ms. Irina Koffler
Ms. Irina Koffler
Investor Relations
Investor Relations
--
--
Dr. Hanit Brenner-lavie
Dr. Hanit Brenner-lavie
Vice President - Clinical Affairs
Vice President - Clinical Affairs
--
--

FAQs

Who are the top five shareholders of Check Cap Ltd?

The top five shareholders of Check Cap Ltd are: Mr. Boaz Shpigelman

How many institutions hold shares of Check Cap Ltd (CHEK)?

As of 2026Q1, 30 institutions hold shares of Check Cap Ltd, with a combined market value of approximately 47.75K, accounting for 0.68% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -132985.00.